- Reported purity
- 98.83%Under 99%
- Test date
- May 29, 2026
- Laboratory named
- AccumarkLabs
Lot details
SE0002
Market
V
Popular
9% below market
on 17 popular peptides
Catalog
9% below market
$ price level · 27 listings
Peptides
25
17 popular carried
COA coverage, in stock
4 of 14
29% of in-stock products · in-stock vendor median 54%
Cheapest on
- NAD+▼ 46%
- LL-37▼ 42%
- TB-500▼ 23%
Price check
Listed prices at Valor Peptides against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
NAD+1000 mg vial · lowest elsewhere $0.05/mg at Peptide Plugs▼ 46%$0.05/mgLL-3710 mg vial · lowest elsewhere $5.40/mg at Simple Peptide▼ 42%$4.60/mgTB-50010 mg vial · lowest elsewhere $3.50/mg at Welli Labs▼ 23%$5/mgKPV10 mg vial · lowest elsewhere $2.90/mg at Welli Labs▼ 20%$4/mgTesamorelin10 mg vial · lowest elsewhere $3.90/mg at retaone▼ 20%$6/mgSS-3110 mg vial · lowest elsewhere $2.70/mg at retaone▼ 15%$5/mg
Below the market median on 12 of 13 comparable listings, above it on 0. Typical listing: 9% below market. Showing the 6 largest differences.
Popular peptides
17 of 22 carriedFull catalog (25)
Product documentation
Valor Peptides COA coverage
Current certificates are on file for 4 of 25 tracked peptide products from Valor Peptides. The public index contains 9 documents. Reported test dates in this set run from Sep 26, 2025 through May 29, 2026. That coverage figure counts the full tracked catalogue for Valor Peptides, including products that are currently out of stock, so it can differ from the in-stock figure above.
- Product coverage
- 4 of 25
- Tested in past year
- 4 of 4
- Older records
- 0
- Most named lab
- Vanguard Laboratory
16% · tracked-vendor median 54%
Based on the printed test date.
Printed date is over 18 months old.
75% of current records that name a lab.
4 current records
View COA
- Reported purity
- 99.79%99.5%+
- Test date
- Oct 27, 2025
- Laboratory named
- Vanguard Laboratory
Lot details
IP0001
- Reported purity
- 99.06%99.0–99.49%
- Test date
- Oct 27, 2025
- Laboratory named
- Vanguard Laboratory
Lot details
TEL0001
- Reported purity
- 99.66%99.5%+
- Test date
- Sep 26, 2025
- Laboratory named
- Vanguard Laboratory
Lot details
ND0001
| Printed lab | Certificate | |||
|---|---|---|---|---|
| Sermorelin | AccumarkLabs | May 29, 2026 | 98.83%Under 99% | View COA |
| Ipamorelin | Vanguard Laboratory | Oct 27, 2025 | 99.79%99.5%+ | View COA |
| Tesamorelin | Vanguard Laboratory | Oct 27, 2025 | 99.06%99.0–99.49% | View COA |
| NAD+ | Vanguard Laboratory | Sep 26, 2025 | 99.66%99.5%+ | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These numbers measure document coverage only. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.